Oregon Center for Clinical Investigations, Inc.
Portland, Oregon 97210
We've found
8 trials
at this facility
Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
Updated: 12/31/1969
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Obsessive-Compulsive Disorder Clinical Trial
Updated: 12/31/1969
BHV-4157 in Adult Subjects With Obsessive Compulsive Disorder
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
ADHD Clinical Trial
Updated: 4/19/2018
KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD
Status: Enrolling,
Phase
III
Updated: 4/19/2018
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
The Object of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials